These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5114183)

  • 21. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
    Jensen GS; Wiseman A; Trotter JF
    Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes.
    Carpenter SP; Lasker JM; Raucy JL
    Mol Pharmacol; 1996 Feb; 49(2):260-8. PubMed ID: 8632758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone disease after liver transplantation.
    Crippin JS
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S27-35. PubMed ID: 11689774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effects of ethanol on the liver and other digestive organs.
    Lieber CS
    Clin Gastroenterol; 1981 May; 10(2):315-42. PubMed ID: 7018747
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of ethanol on amino acid uptake by rat liver cells.
    Rosa J; Rubin E
    Lab Invest; 1980 Oct; 43(4):366-72. PubMed ID: 7003254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethanol-psychotropic drug interactions: pharmacokinetics.
    Sellers EM
    Psychopharmacol Bull; 1984; 20(3):497-9. PubMed ID: 6473655
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunological implications in hepatic physiopathology].
    Nicolaescu T
    Rev Roum Physiol; 1971; 8(4):313-22. PubMed ID: 5128516
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunosuppressive effect of cytostatics in the clinic].
    Gerhartz H
    Schweiz Rundsch Med Prax; 1970 Jul; 59(29):1049-52. PubMed ID: 5512654
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs and the liver.
    Treat Rev; 1998; (No 28):4-6. PubMed ID: 11365425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levetiracetam for seizures after liver transplantation.
    Glass GA; Stankiewicz J; Mithoefer A; Freeman R; Bergethon PR
    Neurology; 2005 Mar; 64(6):1084-5. PubMed ID: 15781837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.
    Mach CM; Fugii H; Wakame K; Smith J
    J Soc Integr Oncol; 2008; 6(3):105-9. PubMed ID: 19087767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunosuppressive therapy in hepatology].
    Bosković D
    Med Glas; 1971; 25(7):285-8. PubMed ID: 5148093
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipid metabolism: reviews of HDL and cholesterol efflux, ethanol and hepatic lipid metabolism and lipid disorders during childhood.
    van Heyningen C
    Curr Opin Lipidol; 2009 Feb; 20(1):77-8. PubMed ID: 19106711
    [No Abstract]   [Full Text] [Related]  

  • 35. [Natural antioxidants as hepatoprotectors].
    Buniatian ND; Gerasimova OA; Sakharova TS; Iakovleva LV
    Eksp Klin Farmakol; 1999; 62(2):64-7. PubMed ID: 10340135
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of liver diseases on drug metabolism.
    Paintaud G; Bechtel Y; Brientini MP; Miguet JP; Bechtel PR
    Therapie; 1996; 51(4):384-9. PubMed ID: 8953814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of chronic diffuse liver diseases with chorionic gonadotropin (a review of the literature)].
    Usov DV; Chesnokov EV
    Lik Sprava; 1995; (3-4):42-6. PubMed ID: 8819919
    [No Abstract]   [Full Text] [Related]  

  • 38. Foreword.
    Hwang GW
    Biol Pharm Bull; 2015; 38(7):960. PubMed ID: 26133702
    [No Abstract]   [Full Text] [Related]  

  • 39. Prescribing for patients with liver disease.
    Arns PA; Branch RA
    Baillieres Clin Gastroenterol; 1989 Jan; 3(1):109-30. PubMed ID: 2655746
    [No Abstract]   [Full Text] [Related]  

  • 40. Subliminal drug-drug interactions: users and their physicians take notice.
    Schenker S; Maddrey WC
    Hepatology; 1991 May; 13(5):995-8. PubMed ID: 2030003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.